retatrutide phase 2 results obesity nejm 2023 trial weight loss Obesity Retatrutide vs Tirzepatide Compared |

Following a thorough analysis of our previous Phase 2b data and trial design, we believe that with the preferred modified release formulation and future trial design optimization, we can advance a competitive oral GLP-1 molecule into registration enabling studies, with the goal of addressing the present and persistent medical needs of people living with obesity. Participants in the study so far have included healthy adults aged 18 years or older and the results thus far have shown a profile that supports once-daily dosing, which is consistent with previous danuglipron studies

M., DeLuca, J

Xiamen Lidamine is specialized in making and supplying Professional food procurement, wholesale, creative, deciding on food packaging and so on for more than 20 years

Wyatt J, Fernando SM, Powell SG, Hill CJ, Arshad I, Probert C, et al